| 1. |
Cerda J, Kashani K, Ostermann M, et al. The global epidemiology of acute kidney injury: challenges and opportunities[J]. Nat Rev Nephrol, 2026, 22(3): 179-198.
|
| 2. |
國家慢性腎病臨床醫學研究中心, 中國醫師協會腎臟內科醫師分會, 中國急性腎損傷臨床實踐指南專家組. 中國急性腎損傷臨床實踐指南[J]. 中華醫學雜志, 2023, 103(42): 3332-3366.
|
| 3. |
Ostermann M, Lumlertgul N, Jeong R, et al. Acute kidney injury[J]. Lancet, 2025, 405(10474): 241-256.
|
| 4. |
Kellum JA, Lameire N, KDIGO AKI Guideline Work Group. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1)[J/OL]. Crit Care, 2013, 17(1): 204. doi: 10.1186/cc11454.
|
| 5. |
Gaudry S, Palevsky PM, Dreyfuss D. Extracorporeal kidney-replacement therapy for acute kidney injury[J]. N Engl J Med, 2022, 386(10): 964-975.
|
| 6. |
Li X, Fan Q, Peng X, et al. Mesenchymal/stromal stem cells: necessary factors in tumour progression[J/OL]. Cell Death Discov, 2022, 8(1): 333. doi: 10.1038/s41420-022-01107-0.
|
| 7. |
Guo J, Wang R, Liu D. Bone marrow-derived mesenchymal stem cells ameliorate sepsis-induced acute kidney injury by promoting mitophagy of renal tubular epithelial cells via the SIRT1/Parkin axis[J/OL]. Front Endocrinol (Lausanne), 2021, 12: 639165. doi: 10.3389/fendo.2021.639165.
|
| 8. |
Begum S, Ahmed N, Mubarak M, et al. Modulation of renal parenchyma in response to allogeneic adipose-derived mesenchymal stem cells transplantation in acute kidney injury[J]. Int J Stem Cells, 2019, 12(1): 125-138.
|
| 9. |
Fahmy SR, Soliman AM, El Ansary M, et al. Therapeutic efficacy of human umbilical cord mesenchymal stem cells transplantation against renal ischemia/reperfusion injury in rats[J]. Tissue Cell, 2017, 49(3): 369-375.
|
| 10. |
Wang Y, Luo P, Wuren T. Narrative review of mesenchymal stem cell therapy in renal diseases: mechanisms, clinical applications, and future directions[J/OL]. Stem Cells Int, 2024, 2024: 8658246. doi: 10.1155/sci/8658246.
|
| 11. |
Huang Y, Yang L. Mesenchymal stem cells and extracellular vesicles in therapy against kidney diseases[J/OL]. Stem Cell Res Ther, 2021, 12(1): 219. doi: 10.1186/s13287-021-02289-7.
|
| 12. |
Ripoll L, Zickler AM, Vader P, et al. Biology and therapeutic potential of extracellular vesicle targeting and uptake[J]. Nat Rev Mol Cell Biol, 2026, 27(5): 358-376.
|
| 13. |
Zhao M, Liu S, Wang C, et al. Mesenchymal stem cell-derived extracellular vesicles attenuate mitochondrial damage and inflammation by stabilizing mitochondrial DNA[J]. ACS Nano, 2021, 15(1): 1519-1538.
|
| 14. |
Zheng C, Sui B, Zhang X, et al. Apoptotic vesicles restore liver macrophage homeostasis to counteract type 2 diabetes[J/OL]. J Extracell Vesicles, 2021, 10(7): e12109. doi: 10.1002/jev2.12109.
|
| 15. |
Pang SHM, D’Rozario J, Mendonca S, et al. Mesenchymal stromal cell apoptosis is required for their therapeutic function[J/OL]. Nat Commun, 2021, 12(1): 6495. doi: 10.1038/s41467-021-26834-3.
|
| 16. |
He X, Hong W, Yang J, et al. Spontaneous apoptosis of cells in therapeutic stem cell preparation exert immunomodulatory effects through release of phosphatidylserine[J/OL]. Signal Transduct Target Ther, 2021, 6(1): 270. doi: 10.1038/s41392-021-00688-z.
|
| 17. |
Wang R, Fu J, He J, et al. Apoptotic mesenchymal stem cells and their secreted apoptotic extracellular vesicles: therapeutic applications and mechanisms[J/OL]. Stem Cell Res Ther, 2025, 16(1): 78. doi: 10.1186/s13287-025-04211-x.
|
| 18. |
Zhang X, Tang J, Kou X, et al. Proteomic analysis of MSC-derived apoptotic vesicles identifies Fas inheritance to ameliorate haemophilia a via activating platelet functions[J/OL]. J Extracell Vesicles, 2022, 11(7): e12240. doi: 10.1002/jev2.12240.
|
| 19. |
Sung CYW, Hayase N, Yuen PST, et al. Macrophage depletion protects against cisplatin-induced ototoxicity and nephrotoxicity[J/OL]. Sci Adv, 2024, 10(30): eadk9878. doi: 10.1126/sciadv.adk9878.
|
| 20. |
Zhang D, Luo G, Jin K, et al. The underlying mechanisms of cisplatin-induced nephrotoxicity and its therapeutic intervention using natural compounds[J]. Naunyn Schmiedebergs Arch Pharmacol, 2023, 396(11): 2925-2941.
|
| 21. |
Tao Y, Zhang M, Chen L, et al. Macrophage AMPK activated by oxidative stress drives profibrotic crosstalk with tubular cells to accelerate renal fibrosis after ischemic and reperfusion injury[J/OL]. Redox Biol, 2026, 90: 104002. doi: 10.1016/j.redox.2025.104002.
|
| 22. |
Lee S, Huen S, Nishio H, et al. Distinct macrophage phenotypes contribute to kidney injury and repair[J]. J Am Soc Nephrol, 2011, 22(2): 317-326.
|
| 23. |
Han H, Gao Y, Chen B, et al. Nrf2 inhibits M1 macrophage polarization to ameliorate renal ischemia-reperfusion injury through antagonizing NF-κB signaling[J/OL]. Int Immunopharmacol, 2024, 143(Pt 1): 113310. doi: 10.1016/j.intimp.2024.113310.
|
| 24. |
Mu Y, Mao Z, Pan S, et al. Macrophage-driven inflammation in acute kidney injury: Therapeutic opportunities and challenges[J]. Transl Res, 2025, 278: 1-9.
|
| 25. |
Meng XM, Wang L, Nikolic-Paterson DJ, et al. Innate immune cells in acute and chronic kidney disease[J]. Nat Rev Nephrol, 2025, 21(7): 464-482.
|
| 26. |
Chen H, Kasagi S, Chia C, et al. Extracellular vesicles from apoptotic cells promote TGFβ production in macrophages and suppress experimental colitis[J/OL]. Sci Rep, 2019, 9(1): 5875. doi: 10.1038/s41598-019-42063-7.
|
| 27. |
Fadok VA, Voelker DR, Campbell PA, et al. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages[J]. J Immunol, 1992, 148(7): 2207-2216.
|
| 28. |
Xu G, Jin J, Fu Z, et al. Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies[J/OL]. Signal Transduct Target Ther, 2025, 10(1): 255. doi: 10.1038/s41392-025-02312-w.
|
| 29. |
Zhao S, Di Y, Fan H, et al. Targeted delivery of extracellular vesicles: the mechanisms, techniques and therapeutic applications[J/OL]. Mol Biomed, 2024, 5(1): 60. doi: 10.1186/s43556-024-00230-x.
|
| 30. |
Cheng L, Hill AF. Therapeutically harnessing extracellular vesicles[J]. Nat Rev Drug Discov, 2022, 21(5): 379-399.
|
| 31. |
Hakulinen J, Sankkila L, Sugiyama N, et al. Secretion of active membrane type 1 matrix metalloproteinase (MMP-14) into extracellular space in microvesicular exosomes[J]. J Cell Biochem, 2008, 105(5): 1211-1218.
|
| 32. |
Valadi H, Ekstr?m K, Bossios A, et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells[J]. Nat Cell Biol, 2007, 9(6): 654-659.
|